1. Home
  2. UBX vs TAIT Comparison

UBX vs TAIT Comparison

Compare UBX & TAIT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • UBX
  • TAIT
  • Stock Information
  • Founded
  • UBX 2009
  • TAIT 1989
  • Country
  • UBX United States
  • TAIT United States
  • Employees
  • UBX N/A
  • TAIT N/A
  • Industry
  • UBX Biotechnology: Pharmaceutical Preparations
  • TAIT Electronic Components
  • Sector
  • UBX Health Care
  • TAIT Technology
  • Exchange
  • UBX Nasdaq
  • TAIT Nasdaq
  • Market Cap
  • UBX 13.9M
  • TAIT 13.1M
  • IPO Year
  • UBX 2018
  • TAIT 1995
  • Fundamental
  • Price
  • UBX $0.78
  • TAIT $2.21
  • Analyst Decision
  • UBX Strong Buy
  • TAIT
  • Analyst Count
  • UBX 3
  • TAIT 0
  • Target Price
  • UBX $4.67
  • TAIT N/A
  • AVG Volume (30 Days)
  • UBX 609.1K
  • TAIT 16.4K
  • Earning Date
  • UBX 08-05-2025
  • TAIT 08-13-2025
  • Dividend Yield
  • UBX N/A
  • TAIT 9.01%
  • EPS Growth
  • UBX N/A
  • TAIT N/A
  • EPS
  • UBX N/A
  • TAIT 0.01
  • Revenue
  • UBX N/A
  • TAIT $4,260,000.00
  • Revenue This Year
  • UBX N/A
  • TAIT N/A
  • Revenue Next Year
  • UBX N/A
  • TAIT N/A
  • P/E Ratio
  • UBX N/A
  • TAIT $225.04
  • Revenue Growth
  • UBX N/A
  • TAIT N/A
  • 52 Week Low
  • UBX $0.36
  • TAIT $2.01
  • 52 Week High
  • UBX $3.10
  • TAIT $3.05
  • Technical
  • Relative Strength Index (RSI)
  • UBX 48.12
  • TAIT 47.75
  • Support Level
  • UBX $0.67
  • TAIT $2.15
  • Resistance Level
  • UBX $0.83
  • TAIT $2.28
  • Average True Range (ATR)
  • UBX 0.09
  • TAIT 0.07
  • MACD
  • UBX 0.01
  • TAIT 0.00
  • Stochastic Oscillator
  • UBX 24.67
  • TAIT 28.00

About UBX Unity Biotechnology Inc.

Unity Biotechnology Inc designs therapeutics that prevent, halt, and reverse various diseases of aging. The company focuses on clearing senescent cells, and creating senolytic medicines. Its medicines target vulnerabilities to senescent cells to clear those cells from the human body while leaving normal cells unaffected. The firm focuses on age-associated diseases such as osteoarthritis, eye diseases, and pulmonary diseases. Its drug candidates include, UBX1325 is being developed for age-related diseases of the eye, including diabetic macular edema, or DME, UBX2089, which is a circulating hormone which is produced in the kidneys and choroid plexus of the brain, which is being researched for multiple neurology indications, and UBX2050.

About TAIT Taitron Components Incorporated

Taitron Components Inc is a supplier of originally designed and manufactured (ODM) products that include value-added engineering and turn-key solutions. It focuses on providing original equipment manufacturers (OEMs) and contracts electronic manufacturers (CEMs) with ODM products for their multi-year turn-key projects and ODM electronic components. The company's product offerings range from discrete semiconductors to small electronic devices. The company also distributes brand-name electronic components with a vast inventory available on hand. Its Taiwan and China locations, provide support for inventory sourcing, purchases, and coordinating the manufacture of ODM Projects and ODM Components.

Share on Social Networks: